Related Experiment Videos
Direct enzyme transfer from lymphocytes corrects a lysosomal storage disease
Biochemical and Biophysical Research Communications
|June 14, 1985
Summary
Mannosidosis fibroblasts corrected their storage defect when exposed to normal lymphocytes. Periodic re-exposure sustained this enzyme replacement therapy effect, suggesting potential for transplantation procedures.
Area of Science:
- Biochemistry
- Genetics
- Cell Biology
Background:
- Mannosidosis is a lysosomal storage disease caused by alpha-D-mannosidase deficiency.
- Affected fibroblasts accumulate mannose-containing oligosaccharides.
Purpose of the Study:
- To investigate the potential for enzyme replacement therapy in mannosidosis using direct cell contact.
- To assess the duration of metabolic correction in mannosidosis fibroblasts.
Main Methods:
- Co-culture of mannosidosis fibroblasts with normal lymphocytes.
- Monitoring the degradation of accumulated oligosaccharides.
- Assessing the sustained correction with periodic re-exposure to lymphocytes.
Main Results:
- Direct contact between normal lymphocytes and mannosidosis fibroblasts led to significant degradation of stored oligosaccharides.
- Prolonged metabolic correction was achieved through periodic renewal of contact with fresh donor lymphocytes.
Conclusions:
- Lymphocyte-mediated enzyme transfer can correct the metabolic defect in mannosidosis fibroblasts.
- This cell-to-cell enzyme delivery mechanism shows promise for future enzyme replacement therapy strategies.